Albany Molecular (AMRI) Files $50M Mixed Shelf
Tweet
Share
E-mailGet Alerts AMRI Hot Sheet
Join SI Premium – FREE
Albany Molecular Research, Inc. (Nasdaq: AMRI), filed a registration with the U.S. Securities and Exchange Commission to sell, from time to time, up to $50 million of Common Stock, Warrants, Units, Preferred Stock, or any combination thereof.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DEFSEC Technologies (DFSC) files for 4.05M share offering by selling stockholders
- 3E Network prices $1M private placement with CEO-linked entity
- Vox Royalty to acquire 2% gold royalty at White Dam for A$5M
Create E-mail Alert Related Categories
Equity OfferingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
